Evaluation of a Pilot Study to Influence Medication Adherence of Patients with Diabetes Mellitus Type-2 by the Pharmacy

Overview

Journal Int J Clin Pharm

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2013 Aug 15

PMID 23942987

Citations 5

Authors

Prem Adhien

Liset van Dijk

Marinke de Vegter

Marnix Westein

Giel Nijpels

Jacqueline G Hugtenburg

Affiliations

Soon will be listed here.

Abstract

Background: Interventions aimed to increase adherence to drug treatment usually are not tailored to the needs of individual patients. A modular pharmacy intervention, named 'Support for Diabetes', was developed to improve adherence to type 2 diabetes treatment.

Objective: To evaluate the implementation of a new care intervention by using focus groups including pharmacy teams, and assess patient satisfaction.

Setting: Community pharmacies in The Netherlands.

Method: The intervention comprises a structured patient interview, an intervention guide and modular interventions tailored to the underlying cause of non-adherence. Feasibility was studied in non-adherent type 2 diabetes mellitus patients, and evaluated by means of focus group interviews with pharmacists and pharmacy technicians. Topics included practicability of the patient selection procedure, patient interviews, materials developed for the intervention and general practitioner (GP) co-operation. Patients' experiences (n = 36) were assessed by means of a questionnaire.

Main Outcome Measure: Feasibility of the intervention and patients' satisfaction.

Results: Pharmacists and pharmacy technicians considered the intervention feasible and appreciated its pro-active approach. Involvement of pharmacy technicians proved a stimulating factor. Poor co-operation with GPs and lack of time as well as financial compensation were interfering factors. Patients appreciated the intervention and reported to follow the advice of pharmacists.

Conclusion: The 'Support for Diabetes' intervention is feasible to implement in pharmacy practice. Poor co-operation between pharmacists and GPs and lack of re-imbursement are obstructions for implementation on a wider scale. These issues should receive attention of pharmacists, policymakers and researchers.

Citing Articles

Collaborative and integrated working between general practice and community pharmacies: A realist review of what works, for whom, and in which contexts.

Owen-Boukra E, Cai Z, Duddy C, Fudge N, Hamer-Hunt J, Husson F J Health Serv Res Policy. 2024; 30(2):136-148.

PMID: 39444067 PMC: 11877979. DOI: 10.1177/13558196241290923.

Pharmacy Technicians and Improving Onychomycosis Treatment Outcomes.

Brown S J Pharm Technol. 2021; 35(2):82-87.

PMID: 34860989 PMC: 6383100. DOI: 10.1177/8755122518815057.

Community Pharmacy-Based Adherence Programs and the Role of Pharmacy Technicians: A Review.

Kadia N, Schroeder M J Pharm Technol. 2021; 31(2):51-57.

PMID: 34860941 PMC: 5990186. DOI: 10.1177/8755122515572809.

Feasibility study of a digitalized nurse practitioner-led intervention to improve medication adherence in type 2 diabetes patients in Dutch primary care.

Hogervorst S, Adriaanse M, Brandt H, Vervloet M, van Dijk L, Hugtenburg J Pilot Feasibility Stud. 2021; 7(1):152.

PMID: 34362471 PMC: 8349070. DOI: 10.1186/s40814-021-00892-2.

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results.

Lelubre M, Clerc O, Grosjean M, Amighi K, De Vriese C, Bugnon O BMC Health Serv Res. 2018; 18(1):874.

PMID: 30458844 PMC: 6247756. DOI: 10.1186/s12913-018-3641-5.

References

Wroe A . Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002; 25(4):355-72. DOI: 10.1023/a:1015866415552. View

Wong L . Focus group discussion: a tool for health and medical research. Singapore Med J. 2008; 49(3):256-60. View

Hugtenburg J, Blom A, Kisoensingh S . Initial phase of chronic medication use; patients' reasons for discontinuation. Br J Clin Pharmacol. 2006; 61(3):352-4. PMC: 1885021. DOI: 10.1111/j.1365-2125.2005.02569.x. View

Lehane E, McCarthy G . Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2006; 44(8):1468-77. DOI: 10.1016/j.ijnurstu.2006.07.010. View

Lee W, Balu S, Cobden D, Joshi A, Pashos C . Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006; 19(7):31-41. View

Herborg H, Haugbolle L, Sorensen L, Rossing C, Dam P . Developing a generic, individualised adherence programme for chronic medication users. Pharm Pract (Granada). 2014; 6(3):148-57. PMC: 4148414. DOI: 10.4321/s1886-36552008000300006. View

Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A . A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003; 169(1):17-22. PMC: 164937. View

Brown K, Rehmus W, Kimball A . Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006; 55(4):607-13. DOI: 10.1016/j.jaad.2005.12.021. View

Krska J, Cromarty J, Arris F, Jamieson D, Hansford D, Duffus P . Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001; 30(3):205-11. DOI: 10.1093/ageing/30.3.205. View

10.

Ho P, Rumsfeld J, Masoudi F, McClure D, Plomondon M, Steiner J . Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17):1836-41. DOI: 10.1001/archinte.166.17.1836. View

11.

Lowry K, Dudley T, Oddone E, Bosworth H . Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005; 39(7-8):1198-203. DOI: 10.1345/aph.1E594. View

12.

Pope C, Ziebland S, Mays N . Qualitative research in health care. Analysing qualitative data. BMJ. 2000; 320(7227):114-6. PMC: 1117368. DOI: 10.1136/bmj.320.7227.114. View

13.

Haynes R, Ackloo E, Sahota N, McDONALD H, Yao X . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI: 10.1002/14651858.CD000011.pub3. View

14.

Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E . Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001; 18(1):63-77. DOI: 10.2165/00002512-200118010-00005. View

15.

Horne R, Weinman J . Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 2000; 47(6):555-67. DOI: 10.1016/s0022-3999(99)00057-4. View

16.

Tinelli M, Ryan M, Bond C . Patients' preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract. 2010; 17(5):275-82. View

17.

Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A . Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2):CD003638. PMC: 9022438. DOI: 10.1002/14651858.CD003638.pub2. View